Concepedia

Patricia de la Cruz‐Ojeda

PD

11

Publications

248

Citations

10

H-Index

2013

Active since

Affiliations

Universidad de Sevilla(Current)

Instituto de Biomedicina de Sevilla

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Instituto de Salud Carlos III

Hospital Universitario Virgen del Rocío

Patricia de la Cruz‐Ojeda is an author at Universidad de Sevilla specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

2013–2022

11

Publications

11

NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPARα Activity

Fabiola Marín‐Aguilar, Beatriz Castejón‐Vega, Elísabet Alcocer‐Gómez et al. · The Journals of Gerontology Series A · 2019 · 55 citations

Long non‐coding <scp>RNA <i>H19</i></scp> as a biomarker for hepatocellular carcinoma

Ángela Rojas, Antonio Gil‐Gómez, Patricia de la Cruz‐Ojeda et al. · Liver International · 2022 · 32 citations

Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells

María Hernández, Patricia de la Cruz‐Ojeda, Paloma Gallego et al. · Biochemical Pharmacology · 2020 · 31 citations

, , +13

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma

Patricia de la Cruz‐Ojeda, Tobias Schmid, Loreto Boix et al. · Cells · 2022 · 27 citations · Full text

Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer

Raúl González, María Hernández, María Negrete et al. · Redox Biology · 2020 · 20 citations · Full text

, , +16

Rows per page

1–5 of 11